TrialCancer prevention research (Philadelphia, Pa.)2022

A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage.

Nwanneka Okwundu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.